Deciphera Pharmaceuticals
Why Robinhood?
You can watch DCPH and buy or sell other stocks, ETFs, and their options commission-free!About DCPH
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors.
DCPH Key Statistics
Stock Snapshot
As of today, Deciphera Pharmaceuticals(DCPH) shares are valued at $25.59. The company's market cap stands at 2.21B, with a P/E ratio of -11.58.
On 2026-03-03, Deciphera Pharmaceuticals(DCPH) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0.
The stock's 52-week range extends from a low of $9.90 to a high of $25.61.
The stock's 52-week range extends from a low of $9.90 to a high of $25.61.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.